Clinical Ophthalmology
Volume 11, 2017 - Issue
Open access
131
Views
9
CrossRef citations to date
0
Altmetric
Original Research
Efficacy of nepafenac ophthalmic suspension 0.1% in improving clinical outcomes following cataract surgery in patients with diabetes: an analysis of two randomized studies
Rishi P Singh1 Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
, Giovanni Staurenghi2 Department of Biomedical and Clinical Science Luigi Sacco, Luigi Sacco Hospital, University of Milan, Milan, Italy
, Ayala Pollack3 Ophthalmology Department, Kaplan Medical Center, Rehovot, Israel
, Adeniyi Adewale4 Alcon Research Ltd., Fort Worth, TX
, Thomas M Walker4 Alcon Research Ltd., Fort Worth, TX
, Dana Sager4 Alcon Research Ltd., Fort Worth, TX
& Robert Lehmann5 Lehmann Eye Center, Nacogdoches, TX, USACorrespondence[email protected]
show all
Pages 1021-1029
|
Published online: 29 May 2017
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.